APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lurasidone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lurasidone Market Outlook and Growth Opportunities 2026

Report ID 174009450431 December 2025190 pages

Choose your research edition.

Industry ResearchLurasidone Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lurasidone Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Lurasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lurasidone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Lurasidone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lurasidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lurasidone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lurasidone market include Zhejiang Hisun Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Square Pharmaceuticals Ltd., RemedyRepack，Inc., Incepta Pharmaceuticals Ltd., Healthcare Pharmaceuticals Limited, Bushu Pharmaceutical, LTD. and Angelini Holding S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lurasidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lurasidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lurasidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lurasidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Lurasidone Segment by Company

Zhejiang Hisun Pharmaceutical Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Square Pharmaceuticals Ltd.

RemedyRepack，Inc.

Incepta Pharmaceuticals Ltd.

Healthcare Pharmaceuticals Limited

Bushu Pharmaceutical, LTD.

Angelini Holding S.p.A.

Lurasidone Segment by Type

120mg/tablet

20mg/tablet

40mg/tablet

60mg/tablet

80mg/tablet

Lurasidone Segment by Application

Hospital

Psychological Clinic

Others

Lurasidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Lurasidone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lurasidone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lurasidone significant trends, drivers, influence factors in global and regions.

6. To analyze Lurasidone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lurasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lurasidone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lurasidone industry.

Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lurasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lurasidone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lurasidone Industry Trends Table 2. Lurasidone Industry Drivers Table 3. Lurasidone Industry Opportunities and Challenges Table 4. Lurasidone Industry Restraints Table 5. Global Lurasidone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lurasidone Revenue Share by Company (2021-2026) Table 7. Global Lurasidone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lurasidone Sales Volume Share by Company (2021-2026) Table 9. Global Lurasidone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lurasidone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lurasidone Key Company Manufacturing Base & Headquarters Table 12. Global Lurasidone Company, Product Type & Application Table 13. Global Lurasidone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lurasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 120mg/tablet Table 18. Significant Companies of 20mg/tablet Table 19. Significant Companies of 40mg/tablet Table 20. Significant Companies of 60mg/tablet Table 21. Significant Companies of 80mg/tablet Table 22. Global Lurasidone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Lurasidone Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Lurasidone Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Lurasidone Sales Volume Share by Type (2021-2026) Table 26. Global Lurasidone Sales Volume Share by Type (2027-2032) Table 27. Global Lurasidone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Lurasidone Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Lurasidone Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Lurasidone Sales Value Share by Type (2021-2026) Table 31. Global Lurasidone Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hospital Table 33. Significant Companies of Psychological Clinic Table 34. Significant Companies of Others Table 35. Global Lurasidone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Lurasidone Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Lurasidone Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Lurasidone Sales Volume Share by Application (2021-2026) Table 39. Global Lurasidone Sales Volume Share by Application (2027-2032) Table 40. Global Lurasidone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Lurasidone Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Lurasidone Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Lurasidone Sales Value Share by Application (2021-2026) Table 44. Global Lurasidone Sales Value Share by Application (2027-2032) Table 45. Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Lurasidone Sales by Region (2021-2026) & (K Units) Table 47. Global Lurasidone Sales Market Share by Region (2021-2026) Table 48. Global Lurasidone Sales by Region (2027-2032) & (K Units) Table 49. Global Lurasidone Sales Market Share by Region (2027-2032) Table 50. Global Lurasidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Lurasidone Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Lurasidone Sales Value Share by Region (2021-2026) Table 53. Global Lurasidone Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Lurasidone Sales Value Share by Region (2027-2032) Table 55. Global Lurasidone Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Lurasidone Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Lurasidone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Lurasidone Sales by Country (2021-2026) & (K Units) Table 60. Global Lurasidone Sales Market Share by Country (2021-2026) Table 61. Global Lurasidone Sales by Country (2027-2032) & (K Units) Table 62. Global Lurasidone Sales Market Share by Country (2027-2032) Table 63. Global Lurasidone Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Lurasidone Sales Value Market Share by Country (2021-2026) Table 65. Global Lurasidone Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Lurasidone Sales Value Market Share by Country (2027-2032) Table 67. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 68. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 69. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio Table 71. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 72. Sumitomo Dainippon Pharma Co., Ltd. Company Information Table 73. Sumitomo Dainippon Pharma Co., Ltd. Business Overview Table 74. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio Table 76. Sumitomo Dainippon Pharma Co., Ltd. Recent Development Table 77. Square Pharmaceuticals Ltd. Company Information Table 78. Square Pharmaceuticals Ltd. Business Overview Table 79. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Square Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 81. Square Pharmaceuticals Ltd. Recent Development Table 82. RemedyRepack，Inc. Company Information Table 83. RemedyRepack，Inc. Business Overview Table 84. RemedyRepack，Inc. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. RemedyRepack，Inc. Lurasidone Product Portfolio Table 86. RemedyRepack，Inc. Recent Development Table 87. Incepta Pharmaceuticals Ltd. Company Information Table 88. Incepta Pharmaceuticals Ltd. Business Overview Table 89. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 91. Incepta Pharmaceuticals Ltd. Recent Development Table 92. Healthcare Pharmaceuticals Limited Company Information Table 93. Healthcare Pharmaceuticals Limited Business Overview Table 94. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio Table 96. Healthcare Pharmaceuticals Limited Recent Development Table 97. Bushu Pharmaceutical, LTD. Company Information Table 98. Bushu Pharmaceutical, LTD. Business Overview Table 99. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio Table 101. Bushu Pharmaceutical, LTD. Recent Development Table 102. Angelini Holding S.p.A. Company Information Table 103. Angelini Holding S.p.A. Business Overview Table 104. Angelini Holding S.p.A. Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Angelini Holding S.p.A. Lurasidone Product Portfolio Table 106. Angelini Holding S.p.A. Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Lurasidone Distributors List Table 110. Lurasidone Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Lurasidone Product Image Figure 2. Global Lurasidone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lurasidone Sales (2021-2032) & (K Units) Figure 5. Global Lurasidone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lurasidone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 120mg/tablet Image Figure 10. 20mg/tablet Image Figure 11. 40mg/tablet Image Figure 12. 60mg/tablet Image Figure 13. 80mg/tablet Image Figure 14. Global Lurasidone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Lurasidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Lurasidone Sales Volume Share by Type (2021-2032) Figure 17. Global Lurasidone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lurasidone Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Lurasidone Sales Value Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Psychological Clinic Image Figure 22. Others Image Figure 23. Global Lurasidone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Lurasidone Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Lurasidone Sales Volume Share by Application (2021-2032) Figure 26. Global Lurasidone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Lurasidone Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Lurasidone Sales Value Share by Application (2021-2032) Figure 29. Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Lurasidone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Lurasidone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Lurasidone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 34. North America Lurasidone Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Lurasidone Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Lurasidone Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 40. South America Lurasidone Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Lurasidone Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Lurasidone Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Lurasidone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Lurasidone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Lurasidone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Lurasidone Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Lurasidone Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg/tablet
  • 20mg/tablet
  • 40mg/tablet
  • 60mg/tablet
  • 80mg/tablet
Applications
  • Hospital
  • Psychological Clinic
  • Others
Companies covered
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Square Pharmaceuticals Ltd.
  • RemedyRepack，Inc.
  • Incepta Pharmaceuticals Ltd.
  • Healthcare Pharmaceuticals Limited
  • Bushu Pharmaceutical, LTD.
  • Angelini Holding S.p.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lurasidone Sales Value (2021-2032)
  4. 1.2.2 Global Lurasidone Sales Volume (2021-2032)
  5. 1.2.3 Global Lurasidone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lurasidone Market Dynamics
  1. 2.1 Lurasidone Industry Trends
  2. 2.2 Lurasidone Industry Drivers
  3. 2.3 Lurasidone Industry Opportunities and Challenges
  4. 2.4 Lurasidone Industry Restraints
3 Lurasidone Market by Company
  1. 3.1 Global Lurasidone Company Revenue Ranking in 2025
  2. 3.2 Global Lurasidone Revenue by Company (2021-2026)
  3. 3.3 Global Lurasidone Sales Volume by Company (2021-2026)
  4. 3.4 Global Lurasidone Average Price by Company (2021-2026)
  5. 3.5 Global Lurasidone Company Ranking (2024-2026)
  6. 3.6 Global Lurasidone Company Manufacturing Base and Headquarters
  7. 3.7 Global Lurasidone Company Product Type and Application
  8. 3.8 Global Lurasidone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lurasidone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lurasidone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lurasidone Market by Type
  1. 4.1 Lurasidone Type Introduction
  2. 4.1.1 120mg/tablet
  3. 4.1.2 20mg/tablet
  4. 4.1.3 40mg/tablet
  5. 4.1.4 60mg/tablet
  6. 4.1.5 80mg/tablet
  7. 4.2 Global Lurasidone Sales Volume by Type
  8. 4.2.1 Global Lurasidone Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Lurasidone Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Lurasidone Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Lurasidone Sales Value by Type
  12. 4.3.1 Global Lurasidone Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Lurasidone Sales Value by Type (2021-2032)
  14. 4.3.3 Global Lurasidone Sales Value Share by Type (2021-2032)
5 Lurasidone Market by Application
  1. 5.1 Lurasidone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Psychological Clinic
  4. 5.1.3 Others
  5. 5.2 Global Lurasidone Sales Volume by Application
  6. 5.2.1 Global Lurasidone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lurasidone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lurasidone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lurasidone Sales Value by Application
  10. 5.3.1 Global Lurasidone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lurasidone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lurasidone Sales Value Share by Application (2021-2032)
6 Lurasidone Regional Sales and Value Analysis
  1. 6.1 Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lurasidone Sales by Region (2021-2032)
  3. 6.2.1 Global Lurasidone Sales by Region: 2021-2026
  4. 6.2.2 Global Lurasidone Sales by Region (2027-2032)
  5. 6.3 Global Lurasidone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lurasidone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lurasidone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lurasidone Sales Value by Region (2027-2032)
  9. 6.5 Global Lurasidone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lurasidone Sales Value (2021-2032)
  12. 6.6.2 North America Lurasidone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lurasidone Sales Value (2021-2032)
  15. 6.7.2 Europe Lurasidone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lurasidone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lurasidone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lurasidone Sales Value (2021-2032)
  21. 6.9.2 South America Lurasidone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lurasidone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lurasidone Sales Value Share by Country, 2025 VS 2032
7 Lurasidone Country-level Sales and Value Analysis
  1. 7.1 Global Lurasidone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lurasidone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lurasidone Sales by Country (2021-2032)
  4. 7.3.1 Global Lurasidone Sales by Country (2021-2026)
  5. 7.3.2 Global Lurasidone Sales by Country (2027-2032)
  6. 7.4 Global Lurasidone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lurasidone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lurasidone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lurasidone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lurasidone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lurasidone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lurasidone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lurasidone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lurasidone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lurasidone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lurasidone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lurasidone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lurasidone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lurasidone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lurasidone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lurasidone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lurasidone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lurasidone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lurasidone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lurasidone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lurasidone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lurasidone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lurasidone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lurasidone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lurasidone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lurasidone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lurasidone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lurasidone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lurasidone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lurasidone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lurasidone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lurasidone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lurasidone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lurasidone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lurasidone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lurasidone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lurasidone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lurasidone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lurasidone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lurasidone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lurasidone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lurasidone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lurasidone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lurasidone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lurasidone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lurasidone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lurasidone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lurasidone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lurasidone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lurasidone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lurasidone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lurasidone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lurasidone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lurasidone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lurasidone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lurasidone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lurasidone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lurasidone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lurasidone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lurasidone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lurasidone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lurasidone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lurasidone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lurasidone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lurasidone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lurasidone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lurasidone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lurasidone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lurasidone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lurasidone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lurasidone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lurasidone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lurasidone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lurasidone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lurasidone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lurasidone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lurasidone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lurasidone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lurasidone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lurasidone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lurasidone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lurasidone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lurasidone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lurasidone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lurasidone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lurasidone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lurasidone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
  6. 8.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sumitomo Dainippon Pharma Co., Ltd.
  8. 8.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
  9. 8.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  10. 8.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
  12. 8.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
  13. 8.3 Square Pharmaceuticals Ltd.
  14. 8.3.1 Square Pharmaceuticals Ltd. Company Information
  15. 8.3.2 Square Pharmaceuticals Ltd. Business Overview
  16. 8.3.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
  18. 8.3.5 Square Pharmaceuticals Ltd. Recent Developments
  19. 8.4 RemedyRepack，Inc.
  20. 8.4.1 RemedyRepack，Inc. Company Information
  21. 8.4.2 RemedyRepack，Inc. Business Overview
  22. 8.4.3 RemedyRepack，Inc. Lurasidone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 RemedyRepack，Inc. Lurasidone Product Portfolio
  24. 8.4.5 RemedyRepack，Inc. Recent Developments
  25. 8.5 Incepta Pharmaceuticals Ltd.
  26. 8.5.1 Incepta Pharmaceuticals Ltd. Company Information
  27. 8.5.2 Incepta Pharmaceuticals Ltd. Business Overview
  28. 8.5.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
  30. 8.5.5 Incepta Pharmaceuticals Ltd. Recent Developments
  31. 8.6 Healthcare Pharmaceuticals Limited
  32. 8.6.1 Healthcare Pharmaceuticals Limited Company Information
  33. 8.6.2 Healthcare Pharmaceuticals Limited Business Overview
  34. 8.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
  36. 8.6.5 Healthcare Pharmaceuticals Limited Recent Developments
  37. 8.7 Bushu Pharmaceutical, LTD.
  38. 8.7.1 Bushu Pharmaceutical, LTD. Company Information
  39. 8.7.2 Bushu Pharmaceutical, LTD. Business Overview
  40. 8.7.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
  42. 8.7.5 Bushu Pharmaceutical, LTD. Recent Developments
  43. 8.8 Angelini Holding S.p.A.
  44. 8.8.1 Angelini Holding S.p.A. Company Information
  45. 8.8.2 Angelini Holding S.p.A. Business Overview
  46. 8.8.3 Angelini Holding S.p.A. Lurasidone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
  48. 8.8.5 Angelini Holding S.p.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lurasidone Value Chain Analysis
  2. 9.1.1 Lurasidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lurasidone Sales Mode & Process
  6. 9.2 Lurasidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lurasidone Distributors
  9. 9.2.3 Lurasidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst